+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Quinoxalin-2(1H)-one derived AMPA-receptor antagonists: Design, synthesis, molecular docking and anticonvulsant activity



Quinoxalin-2(1H)-one derived AMPA-receptor antagonists: Design, synthesis, molecular docking and anticonvulsant activity



Medicinal Chemistry Research 26(11): 2967-2984




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065040063

Download citation: RISBibTeXText

DOI: 10.1007/s00044-017-1996-5


Related references

Design, molecular docking and synthesis of some novel 4-acetyl-1-substituted-3,4-dihydroquinoxalin-2(1H)-one derivatives for anticonvulsant evaluation as AMPA-receptor antagonists. Medicinal Chemistry Research 25(12): 3030-3046, 2016

Phthalazine-1,4-dione derivatives as non-competitive AMPA receptor antagonists: design, synthesis, anticonvulsant evaluation, ADMET profile and molecular docking. Molecular Diversity 23(2): 283-298, 2019

Design, synthesis and molecular docking study of novel quinoxalin-2(1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activity. European Journal of Medicinal Chemistry 86: 122-132, 2014

Synthesis and anticonvulsant activity of new 2,3-benzodiazepines as AMPA receptor antagonists. Farmaco 54(3): 178-187, 1999

Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists. Journal of Medicinal Chemistry 42(21): 4414-4421, 1999

Design, synthesis and structure-activity relationship of novel quinoxalin-2-carboxamides as 5-HT3 receptor antagonists for the management of depression. Bioorganic and Medicinal Chemistry Letters 20(22): 6773-6776, 2010

AMPA/GluR5 kainate receptor-selective antagonist LY293558 has broad-spectrum anticonvulsant activity and improved toxicity profile compared with conventional AMPA receptor antagonists. Epilepsia 39(Suppl. 6): 39, 1998

Novel potent AMPA/kainate receptor antagonists Synthesis and anticonvulsant activity of a series of 2- - methyl-4,5-methylenedioxyphenylacetic acid alkyl esters. Journal of Medicinal Chemistry 45(20): 4433-4442, 2002

Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists. Bioorganic and Medicinal Chemistry 23(8): 1788-1799, 2015

Novel potent AMPA/kainate receptor antagonists: synthesis and anticonvulsant activity of a series of 2-[(4-alkylsemicarbazono)-(4-amino-phenyl)methyl]-4,5-methylenedioxyphenylacetic acid alkyl esters. Journal of Medicinal Chemistry 45(20): 4433-4442, 2002

Coumarinyl pyranopyrimidines as new neuropeptide S receptor antagonists; design, synthesis, homology and molecular docking. Bioorganic Chemistry 75: 274-290, 2017

Design, synthesis and structure-activity relationships of novel triazinones as non-competitive AMPA receptor antagonists. Abstracts of Papers American Chemical Society 226(1-2): MEDI 169, 2003

Synthesis and anticonvulsant evaluation of N-substituted isoquinoline AMPA receptor antagonists. Bioorganic and Medicinal Chemistry 16(5): 2379-2384, 2008

Design, synthesis and structure activity relationship studies for imidazolyl quinoxalines as AMPA receptor antagonists. Abstracts of Papers American Chemical Society 207(1-2): MEDI 178, 1994

Synthesis and anticonvulsant activity of 3-aryl-5H-2,3-benzodiazepine AMPA antagonists. Bioorganic & Medicinal Chemistry Letters 9(14): 1953-1956, 1999